Risks stratification for invasive aspergillosis: Early assesment of host susceptibility

Thomas F. Patterson

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


Outcomes of invasive aspergillosis are substantially improved with early initiation of therapy. Unfortunately, the diagnosis remains difficult to establish so that early suspicion of infection is imperative. Identification of high risk patients and use of non-culture-based diagnostics and radiographic studies can facilitate earlier recognition of infection. It is important to realize that the timing and spectrum of risk for invasive aspergillosis have expanded. While patients with hematological malignancies and hematopoietic stem cell transplants make up the highest risk groups, patients such as those receiving steroids and other immunosuppressive therapies are also at risk. Non-culture-based methods (including galactomannan, 1,3-beta-D-glucan, and PCR-based methods) are actively being pursued to improve early diagnosis. Thus, identifying patients at high risk for infection and utilizing non-culture-based methods and radiologic studies to assist in establishing a likely diagnosis of invasive aspergillosis will further enhance the role of new agents in the early, effective treatment and prophylaxis of invasive aspergillosis.

Original languageEnglish (US)
Pages (from-to)S255-S260
JournalMedical mycology
Issue numberSUPPL. 1
StatePublished - 2009


  • Diagnosis
  • Epidemiology
  • Invasive aspergillosis
  • Non-culture-based diagnostics
  • Therapy

ASJC Scopus subject areas

  • Infectious Diseases


Dive into the research topics of 'Risks stratification for invasive aspergillosis: Early assesment of host susceptibility'. Together they form a unique fingerprint.

Cite this